In an interview with CNBC-TV18, Mark Saldanha, Chairman of Marksans Pharma said the acquisition with Time Cap Laboratories will help in improving company's profitability and will help it entering the US market.
first published: Jun 30, 2015 11:45 am
A collection of the most-viewed Moneycontrol videos.
Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.
Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
Live: Can Nifty snap 3-day losing streak after Fed's policy outcome? | Opening Bell
